| Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling Q Yang, S Zhao, Z Shi, L Cao, J Liu, T Pan, D Zhou, J Zhang Journal of Experimental & Clinical Cancer Research 40, 1-18, 2021 | 93 | 2021 |
| Sabutoclax, pan-active BCL-2 protein family antagonist, overcomes drug resistance and eliminates cancer stem cells in breast cancer Y Hu, E Yagüe, J Zhao, L Wang, J Bai, Q Yang, T Pan, H Zhao, J Liu, ... Cancer letters 423, 47-59, 2018 | 63 | 2018 |
| Centromere protein U (CENPU) enhances angiogenesis in triple-negative breast cancer by inhibiting ubiquitin–proteasomal degradation of COX-2 T Pan, D Zhou, Z Shi, Y Qiu, G Zhou, J Liu, Q Yang, L Cao, J Zhang Cancer Letters 482, 102-111, 2020 | 30 | 2020 |
| FBXL19-AS1 promotes cell proliferation and inhibits cell apoptosis via miR-876-5p/FOXM1 axis in breast cancer G Dong, T Pan, D Zhou, C Li, J Liu, J Zhang Acta Biochimica et Biophysica Sinica 51 (11), 1106-1113, 2019 | 22 | 2019 |
| GGNBP2 suppresses triple-negative breast cancer aggressiveness through inhibition of IL-6/STAT3 signaling activation J Liu, L Liu, E Yagüe, Q Yang, T Pan, H Zhao, Y Hu, J Zhang Breast Cancer Research and Treatment 174, 65-78, 2019 | 22 | 2019 |
| Comparison of different scoring systems for prediction of mortality and ICU admission in elderly CAP population C Lv, Y Chen, W Shi, T Pan, J Deng, J Xu Clinical Interventions in Aging, 1917-1929, 2021 | 21 | 2021 |
| Chidamide combined with doxorubicin induced p53-driven cell cycle arrest and cell apoptosis reverse multidrug resistance of breast cancer L Cao, S Zhao, Q Yang, Z Shi, J Liu, T Pan, D Zhou, J Zhang Frontiers in Oncology 11, 614458, 2021 | 21 | 2021 |
| Exosomal transfer of miR-181b-5p confers senescence-mediated doxorubicin resistance via modulating BCLAF1 in breast cancer S Zhao, T Pan, J Deng, L Cao, JM Vicencio, J Liu, G Zhou, T Ng, J Zhang British Journal of Cancer 128 (4), 665-677, 2023 | 14 | 2023 |
| Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans JM Vicencio, R Evans, R Green, Z An, J Deng, C Treacy, R Mustapha, ... Cell Death & Disease 13 (3), 274, 2022 | 14 | 2022 |
| The role of TXNIP in cancer: a fine balance between redox, metabolic, and immunological tumor control J Deng, T Pan, Z Liu, C McCarthy, JM Vicencio, L Cao, G Alfano, ... British Journal of Cancer 129 (12), 1877-1892, 2023 | 6 | 2023 |
| Exploration of prognostic factors for prediction of mortality in elderly CAP population using a nomogram model C Lv, M Li, W Shi, T Pan, A Muhith, W Peng, J Xu, J Deng Frontiers in Medicine 9, 976148, 2022 | 6 | 2022 |
| Deciphering the performance of polo-like kinase 1 in triple-negative breast cancer progression according to the centromere protein U-phosphorylation pathway S Zhao, Y Geng, L Cao, Q Yang, T Pan, D Zhou, J Liu, Z Shi, J Zhang American journal of cancer research 11 (5), 2142, 2021 | 6 | 2021 |
| Correlation of radiotherapy with prognosis of elderly patients with hormone receptor-positive breast cancer according to immunohistochemical subtyping X Zhi, X Yang, T Pan, J Liu, X Chen, L Lou, Z Shi, J Zhang Chinese Journal of Cancer Research 31 (3), 471, 2019 | 6 | 2019 |
| Prognostic significance of cuproptosis-related gene signatures in breast Cancer based on Transcriptomic Data Analysis Z Zhou, J Deng, T Pan, Z Zhu, X Zhou, C Lv, H Li, W Peng, B Lin, C Cai, ... Cancers 14 (23), 5771, 2022 | 4 | 2022 |
| Exploration of aging-care parameters to predict mortality of patients aged 80-years and above with community-acquired pneumonia C Lv, W Shi, T Pan, H Li, W Peng, J Xu, J Deng Clinical interventions in aging, 1379-1391, 2022 | 4 | 2022 |
| Exosomal transfer leads to chemoresistance through oxidative phosphorylation-mediated stemness phenotype in colorectal cancer J Deng, T Pan, C Lv, L Cao, L Li, X Zhou, G Li, H Li, JM Vicencio, Y Xu, ... Theranostics 13 (14), 5057, 2023 | 2 | 2023 |
| Establishment of risk model for elderly CAP at different age stages: a single-center retrospective observational study C Lv, T Pan, W Shi, W Peng, Y Gao, A Muhith, Y Mu, J Xu, J Deng, W Wei Scientific Reports 13 (1), 12432, 2023 | 1 | 2023 |
| Chidamide combined with doxorubicin induced p53-driven cell cycle arrest and cell apoptosis reverse multidrug resistance of breast cancer CAO Lixia, S Zhao, Q Yang, Z Shi, J Liu, T Pan, D Zhou, J Zhang | 1 | 2020 |
| Targeting MUS81 endonuclease to enhance chemo-immunotherapy response in head and neck squamous cell carcinoma AA Suwaidan, A Pasto, C McCarthy, T Pan, J Deng, L Dolcetti, G Alfano, ... Cancer Research 84 (6_Supplement), 2040-2040, 2024 | | 2024 |
| Manually-established abnormal karyotype dataset based on normal chromosomes effectively train artificial intelligence model for better cytogenetic abnormalities prediction J Deng, W Peng, Q Lu, Z Wang, Q Fu, X Zhou, Y Cai, Y Mu, T Pan, Z Liu, ... | | 2023 |
